Who is sponsoring NCT03660891?

NCT03660891 is sponsored by AZ Sint-Jan AV.

What drugs are being tested in NCT03660891?

Interventions in NCT03660891: measuring neuromuscular block.

What condition does NCT03660891 study?

NCT03660891 studies Neuromuscular Blockade.

Is NCT03660891 still recruiting?

NCT03660891 is currently status unknown. Last updated 23 March 2020.

Last reviewed 2020-03-23 · How we verify

NCT03660891

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

OS NMB Depth Measured by Central and Peripheral Monitor.

Status unknown Last updated 23 March 2020

What this trial tests

trial testing measuring neuromuscular block in Neuromuscular Blockade in 20 participants. Status unknown.

Timeline

1 August 2020

Primary endpoint
30 December 2020

31 December 2021

Quick facts

Lead sponsor	AZ Sint-Jan AV
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	20
Start date	1 August 2020
Primary completion	30 December 2020
Estimated completion	31 December 2021
Sites	1 location across Belgium

Drugs / interventions tested

measuring neuromuscular block

Conditions studied

Neuromuscular Blockade — all drugs for Neuromuscular Blockade →

Sponsor

AZ Sint-Jan AV — full company profile →

Who can join

18 and older, any sex, with Neuromuscular Blockade. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Comparing during anesthesia in the same patient 2 neuromuscular monitors on the same arm.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Neuromuscular Blockade

Currently open trials in the same condition.

NCT07203287 — Risk of Acute Complications With Rocuronium vs Cisatracurium in Patients With Chronic Kidney Disease · Phase 4 · recruiting
NCT06945341 — International Focus Group Discussion on Neuromuscular Monitoring. · recruiting
NCT06948409 — NMBA Reversal and Postoperative Urinary Retention · active not recruiting
NCT07003061 — Sarcopenia and Neuromuscular Block in Gastrointestinal Cancer Surgery · recruiting
NCT06679569 — Deep Neuromuscular Blockade on Postoperative Pain · NA · recruiting

Other AZ Sint-Jan AV trials

Trials by the same sponsor.

NCT07501481 — Arrhythmic Risk in Myocarditis Outcome Research · not yet recruiting
NCT04784039 — D-Dimer-based Indication for Transesophageal Echocardiography to Exclude Left Atrial Thrombus Before Cardioversion of No · Phase 4 · unknown
NCT06095765 — Colchicine in Belgium in Patients With Coronary Artery Disease After Percutaneous Coronary Intervention · Phase 3 · recruiting
NCT05577078 — TriBEL Registry: National Belgian Registry of Percutaneous Tricuspid Valve Repair Using a Transcatheter Edge-to-edge Rep · not yet recruiting
NCT05365568 — Left Bundle Branch Area Pacing Using Conventional Stylet-driven Pacemaker Leads for Cardiac Resynchronization Therapy · NA · active not recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03660891 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by AZ Sint-Jan AV
Last refreshed: 23 March 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03660891.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing